Friday, November 22, 2024
HomeTagsEirGenix

EirGenix

Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA

Sandoz, a global leader in generic and biosimilar medicines, announced that it has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics